0001487371-16-000192.txt : 20160125
0001487371-16-000192.hdr.sgml : 20160125
20160125194700
ACCESSION NUMBER: 0001487371-16-000192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160121
FILED AS OF DATE: 20160125
DATE AS OF CHANGE: 20160125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GenMark Diagnostics, Inc.
CENTRAL INDEX KEY: 0001487371
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 272053069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 448-4300
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MASSARANY HANY
CENTRAL INDEX KEY: 0001134554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34753
FILM NUMBER: 161359769
MAIL ADDRESS:
STREET 1: 1910 INNOVATION PARK DR
CITY: TUCSON
STATE: AZ
ZIP: 85737
4
1
wf-form4_145376920927739.xml
FORM 4
X0306
4
2016-01-21
0
0001487371
GenMark Diagnostics, Inc.
GNMK
0001134554
MASSARANY HANY
5964 LA PLACE COURT
CARLSBAD
CA
92008
1
1
0
0
President and CEO
Common Stock
2016-01-21
4
M
0
1466
0
A
80205
D
Common Stock
2016-01-21
4
S
0
648
6.80
D
79557
D
Common Stock
406729
I
Massarany Family Trust dated November 15, 2012
Market Stock Units
0.0
2016-01-21
4
M
0
1466
0
D
Common Stock
1466.0
46584
D
The reporting person transferred 818 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable market stock units ("MSUs") vesting event.
The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted MSUs.
Mr. Massarany is the trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.
Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
/s/ Eric Stier, Attorney-in-fact
2016-01-25